AU2001290902A1 - Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators - Google Patents

Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators

Info

Publication number
AU2001290902A1
AU2001290902A1 AU2001290902A AU9090201A AU2001290902A1 AU 2001290902 A1 AU2001290902 A1 AU 2001290902A1 AU 2001290902 A AU2001290902 A AU 2001290902A AU 9090201 A AU9090201 A AU 9090201A AU 2001290902 A1 AU2001290902 A1 AU 2001290902A1
Authority
AU
Australia
Prior art keywords
methods
colorectal cancer
diagnosis
screening
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001290902A
Inventor
Kurt C. Gish
David H. Mack
Keith E. Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EOS Biotechnology Inc
Original Assignee
EOS Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EOS Biotechnology Inc filed Critical EOS Biotechnology Inc
Publication of AU2001290902A1 publication Critical patent/AU2001290902A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57415Specifically defined cancers of breast
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0004Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57419Specifically defined cancers of colon
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001290902A 2000-09-15 2001-09-14 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators Abandoned AU2001290902A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US66373300A 2000-09-15 2000-09-15
US09/663,733 2000-09-15
US09/930,020 US20030077568A1 (en) 2000-09-15 2001-08-14 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators
US09/930,020 2001-08-14
PCT/US2001/028716 WO2002021996A2 (en) 2000-09-15 2001-09-14 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators

Publications (1)

Publication Number Publication Date
AU2001290902A1 true AU2001290902A1 (en) 2002-03-26

Family

ID=27098811

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001290902A Abandoned AU2001290902A1 (en) 2000-09-15 2001-09-14 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators

Country Status (7)

Country Link
US (1) US20030077568A1 (en)
EP (1) EP1317669A4 (en)
JP (1) JP2004515225A (en)
AU (1) AU2001290902A1 (en)
CA (1) CA2422278A1 (en)
MX (1) MXPA03002323A (en)
WO (1) WO2002021996A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030064946A1 (en) * 2000-08-09 2003-04-03 Mcswiggen James Method and reagent for the inhibition of calcium activated chloride channel-1 (CLCA-1)
US20050233353A1 (en) * 2001-02-27 2005-10-20 Markowitz Sanford D Methods and compositions for categorizing patients
US7081516B2 (en) 2002-08-26 2006-07-25 Case Western Reserve University Methods for categorizing patients
US7118912B2 (en) 2002-08-26 2006-10-10 Case Western Reserve University Methods and compositions for categorizing patients
US20060035237A1 (en) * 2002-08-26 2006-02-16 Markowitz Sanford D Methods and compositions for categorizing patients
GB0208089D0 (en) * 2002-04-09 2002-05-22 Oxford Glycosciences Uk Ltd Protein
US20040014047A1 (en) * 2002-07-18 2004-01-22 Isis Pharmaceuticals Inc. Antisense modulation of LIM domain kinase 1 expression
EP1546730A2 (en) * 2002-09-30 2005-06-29 Oncotherapy Science, Inc. Method for treating or preventing metastasis of colorectal cancers
US7105657B2 (en) * 2002-11-08 2006-09-12 Board Of Regents Of The University Of Nebraska Compositions and methods for inhibiting pancreatic cancer metastasis
US20060241035A1 (en) 2003-07-11 2006-10-26 Daria Onichtchouk Use of dg153 secreted protein products for preventing and treating pancreatic disease and/or obesity and/or metabolic syndrome
US20080199468A1 (en) * 2004-02-24 2008-08-21 Oncotherapy Science, Inc. Method For Diagnosing Colorectal Cancers
EP1856286A2 (en) * 2005-02-11 2007-11-21 Wisconsin Alumni Research Foundation Mir-155 assay
BRPI0607507A2 (en) 2005-04-13 2009-09-08 Consejo Superior Investigacion in vitro method for the identification of cancer treatment compounds
EP2166357A1 (en) * 2005-08-18 2010-03-24 Zadec Aps Protein marker for diagnosing colorectal cancer
NZ544432A (en) * 2005-12-23 2009-07-31 Pacific Edge Biotechnology Ltd Prognosis prediction for colorectal cancer using a prognositc signature comprising markers ME2 and FAS
ES2491222T3 (en) 2006-01-11 2014-09-05 Genomic Health, Inc. Gene expression markers for colorectal cancer prognosis
EP2198306A1 (en) * 2007-09-06 2010-06-23 Case Western Reserve University Methods for diagnosing and treating cancers
EP2644711B1 (en) * 2007-10-23 2018-07-04 Clinical Genomics Pty Ltd A method of diagnosing neoplasms - II
SG10201401722XA (en) * 2009-05-01 2014-08-28 Genomic Health Inc Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer andresponse to chemotherapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356817A (en) * 1988-06-09 1994-10-18 Yale University Methods for detecting the onset, progression and regression of gynecologic cancers
CA2369319A1 (en) * 1999-03-15 2000-09-21 Eos Biotechnology, Inc. Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators

Also Published As

Publication number Publication date
CA2422278A1 (en) 2002-03-21
WO2002021996A3 (en) 2003-02-06
MXPA03002323A (en) 2003-08-01
WO2002021996A2 (en) 2002-03-21
EP1317669A4 (en) 2005-04-06
JP2004515225A (en) 2004-05-27
US20030077568A1 (en) 2003-04-24
EP1317669A2 (en) 2003-06-11

Similar Documents

Publication Publication Date Title
AU2002252144A1 (en) Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer
AU2002215345A1 (en) Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
AU2002309583A1 (en) Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
AU2002347428A1 (en) Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
AU2002245317A1 (en) Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
AU2002330039A1 (en) Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer
AU2001231199A1 (en) Compositions and methods for the early diagnosis of ovarian cancer
AU2001290902A1 (en) Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators
AU2002257004A1 (en) Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators
AU2001265296A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2002249871A1 (en) Novel methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators
AU2002339865A1 (en) Methods and compositions useful for diagnosis, staging, and treatment of cancers and tumors
AU2001268259A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU3491001A (en) Compositions and methods for the early diagnosis of ovarian cancer
AU3755300A (en) Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
AU2001269766A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU3752700A (en) Novel methods of diagnosing and treating breast cancer, compositions, and methods of screening for breast cancer modulators
AU6902200A (en) Novel methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators
AU2001280982A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002364708A1 (en) Novel compositions and methods for cancer
AU2002246519A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002239431A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2001290518A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002357734A1 (en) Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
AU2002337943A1 (en) Novel compositions and methods for cancer